CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
Recalls → D-0076-2027
Class II Recall · D-0076-2027 Report Date: 2026-10-28 · Status: Ongoing

Hikma Pharmaceuticals USA INC. — Pharmaceuticals & Sterile/OTC Drugs Recall

Product Description: Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.
Reason for Recall: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
Distribution Pattern: Nationwide within the United States
View Linked Facility Profile (FEI FEI-95060FDC) → Verify on openFDA ↗